About CONTINUITY BIOSCIENCES, LLC
Continuity Biosciences develops adaptive precision delivery platforms to enhance therapeutic impact by delivering treatments directly to target tissues. The company combines advanced engineering with biological insights to support a wide range of therapeutic applications.
Implantable iontophoretic systems for targeted chemotherapy deliverySubcutaneously implantable combination products for insulin-producing cell supportSubdermal implants for sustained therapy deliveryNanofluidic drug-eluting seeds for localized tumor therapyPatch technology for intradermal precision delivery in medical aesthetics
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TRE | Department of Health and Human Services | $3.0M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CONTINUITY BIOSCIENCES, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.